Celgene wins FDA approval for its blockbuster arthritis contender

Damian Garde

picked up the FDA's blessing for the much-debated apremilast, winning to market the oral drug as a treatment for psoriatic in step one of its plan.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS